ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI In November

December 28, 2001

Congress Reaffirms GRH FY 1986 Cuts

July 25, 1986

In Brief: Francis Giles named deputy director of Lurie Cancer Center

October 17, 2014

FOCR Report Offers Recommendations, Definitions for CER

May 22, 2009

CMS Unable to Adjust Cuts To Cancer Care

June 7, 2013

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985